Reported vancomycin-intermediate staphylococcus aureus infection surveillance for United States (USA) — — latest record 2026-10-25
As of 25 October 2026, the United States has reported 24 Vancomycin-intermediate Staphylococcus aureus infection cases in 2026, compiled from figures published by CDC NNDSS Weekly Notifiable Diseases (State-Level). The full year 2025 closed at 38 cases.
Of the 1 countries reporting vancomycin-intermediate staphylococcus aureus infection to ENCLAI in 2026, United States accounts for 100.0% of reported cases and ranks 1 by case count.
ENCLAI has logged 362 surveillance records for vancomycin-intermediate staphylococcus aureus infection in United States in 2026, with the most detailed reporting in Aug 2026 (60 records). 39 of those arrived in the last 30 days; the case counts run to 2026-10-25. 1 distinct surveillance sources reported this pair in 2026.
Reporting authorities for these counts: CDC NNDSS Weekly Notifiable Diseases (State-Level)
One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.
| Year | Reported cases | Share of worldwide reports |
|---|---|---|
| 2023 | not reported | — |
| 2024 | incomplete year | — |
| 2025 | 38 | 100.0% |
| 2026 (year to date) | 24 | 100.0% |
Reporting bounds and case definitions vary; historical baselines are a separate comparison measure. Worldwide share compares this country's reported figure with the sum of all countries reporting vancomycin-intermediate staphylococcus aureus infection to ENCLAI for that year. "Incomplete year" means our sources cover less than ten months of that year, so no full-year figure is shown; "outbreak total to date" is a running total since an outbreak began, not a count for one year.
| Month | Records | Reporting sources |
|---|---|---|
| Jan 2026 | 17 | 1 |
| Feb 2026 | 4 | 1 |
| Mar 2026 | 19 | 1 |
| Apr 2026 | 23 | 1 |
| May 2026 | 44 | 1 |
| Jun 2026 | 44 | 1 |
| Jul 2026 | 48 | 1 |
| Aug 2026 | 60 | 1 |
| Sep 2026 | 51 | 1 |
| Oct 2026 | 52 | 1 |
A record is one dated surveillance publication or one row of an official table; a month with many records is a month with detailed reporting, not necessarily more cases. 39 records were logged in the last 30 days.
Areas within United States with the most vancomycin-intermediate staphylococcus aureus infection records this year:
| Area | Records |
|---|---|
| Michigan | 38 |
| Pennsylvania | 35 |
| North Dakota | 34 |
| Indiana | 32 |
| Massachusetts | 30 |
| Disease | 2026 cases | Trend |
|---|---|---|
| Chlamydia infection | 620,278 | |
| Gonococcal infection | 202,064 | |
| Hepatitis C | 62,543 | ▲ Rising · 2025 |
| Campylobacteriosis | 38,167 | ▲ Rising · 2025 |
| Non-typhoidal salmonellosis | 26,618 |
Track vancomycin-intermediate staphylococcus aureus infection in United States live — alerts, exports and sub-national drill-down: start a 7-day free trial or request a demo.
One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.
